590 related articles for article (PubMed ID: 19015208)
21. Improved differentiation between Churg-Strauss syndrome and Wegener's granulomatosis by an artificial neural network.
Schmitt WH; Linder R; Reinhold-Keller E; Gross WL
Arthritis Rheum; 2001 Aug; 44(8):1887-96. PubMed ID: 11508442
[TBL] [Abstract][Full Text] [Related]
22. The frequency of anticardiolipin antibodies and genetic mutations associated with hypercoagulability among patients with Wegener's granulomatosis with and without history of a thrombotic event.
Sebastian JK; Voetsch B; Stone JH; Romay-Penabad Z; Lo GH; Allen NB; Davis JC; Hoffman GS; McCune WJ; St Clair EW; Specks U; Spiera R; Loscalzo J; Pierangeli S; Merkel PA;
J Rheumatol; 2007 Dec; 34(12):2446-50. PubMed ID: 17918782
[TBL] [Abstract][Full Text] [Related]
23. Clinical relevance of elevated serum thrombomodulin and soluble E-selectin in patients with Wegener's granulomatosis and other systemic vasculitides.
Boehme MW; Schmitt WH; Youinou P; Stremmel WR; Gross WL
Am J Med; 1996 Oct; 101(4):387-94. PubMed ID: 8873509
[TBL] [Abstract][Full Text] [Related]
24. Malignancy is increased in ANCA-associated vasculitis.
Pankhurst T; Savage CO; Gordon C; Harper L
Rheumatology (Oxford); 2004 Dec; 43(12):1532-5. PubMed ID: 15316126
[TBL] [Abstract][Full Text] [Related]
25. Prevalences of polyarteritis nodosa, microscopic polyangiitis, Wegener's granulomatosis, and Churg-Strauss syndrome in a French urban multiethnic population in 2000: a capture-recapture estimate.
Mahr A; Guillevin L; Poissonnet M; Aymé S
Arthritis Rheum; 2004 Feb; 51(1):92-9. PubMed ID: 14872461
[TBL] [Abstract][Full Text] [Related]
26. Antineutrophil cytoplasmic antibody-associated vasculitides: could geographic patterns be explained by ambient ultraviolet radiation?
Gatenby PA; Lucas RM; Engelsen O; Ponsonby AL; Clements M
Arthritis Rheum; 2009 Oct; 61(10):1417-24. PubMed ID: 19790114
[TBL] [Abstract][Full Text] [Related]
27. Uncommon presentations of primary systemic necrotizing vasculitides: the Great Masquerades.
Sharma A; Gopalakrishan D; Nada R; Kumar S; Dogra S; Aggarwal MM; Gupta R; Minz RW; Kakkar N; Vashishtha RK; Singh S
Int J Rheum Dis; 2014 Jun; 17(5):562-72. PubMed ID: 24237487
[TBL] [Abstract][Full Text] [Related]
28. Clinical features and outcomes in 348 patients with polyarteritis nodosa: a systematic retrospective study of patients diagnosed between 1963 and 2005 and entered into the French Vasculitis Study Group Database.
Pagnoux C; Seror R; Henegar C; Mahr A; Cohen P; Le Guern V; Bienvenu B; Mouthon L; Guillevin L;
Arthritis Rheum; 2010 Feb; 62(2):616-26. PubMed ID: 20112401
[TBL] [Abstract][Full Text] [Related]
29. Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies.
Watts R; Lane S; Hanslik T; Hauser T; Hellmich B; Koldingsnes W; Mahr A; Segelmark M; Cohen-Tervaert JW; Scott D
Ann Rheum Dis; 2007 Feb; 66(2):222-7. PubMed ID: 16901958
[TBL] [Abstract][Full Text] [Related]
30. Peripheral neuropathy in Wegener's granulomatosis, Churg-Strauss syndrome and microscopic polyangiitis.
Cattaneo L; Chierici E; Pavone L; Grasselli C; Manganelli P; Buzio C; Pavesi G
J Neurol Neurosurg Psychiatry; 2007 Oct; 78(10):1119-23. PubMed ID: 17299018
[TBL] [Abstract][Full Text] [Related]
31. Association of cigarette smoking with organ damage in primary systemic vasculitis.
Mohammad AJ; Segelmark M
Scand J Rheumatol; 2011 Jan; 40(1):51-6. PubMed ID: 20858142
[TBL] [Abstract][Full Text] [Related]
32. Comparison of cutaneous manifestations in systemic polyarteritis nodosa and microscopic polyangiitis.
Kluger N; Pagnoux C; Guillevin L; Francès C;
Br J Dermatol; 2008 Sep; 159(3):615-20. PubMed ID: 18647311
[TBL] [Abstract][Full Text] [Related]
33. Stable incidence of primary systemic vasculitides over five years: results from the German vasculitis register.
Reinhold-Keller E; Herlyn K; Wagner-Bastmeyer R; Gross WL
Arthritis Rheum; 2005 Feb; 53(1):93-9. PubMed ID: 15696553
[TBL] [Abstract][Full Text] [Related]
34. Immunopathology of ANCA-associated vasculitis.
Csernok E; Müller A; Gross WL
Intern Med; 1999 Oct; 38(10):759-65. PubMed ID: 10526937
[TBL] [Abstract][Full Text] [Related]
35. [ANCA-associated vasculitis (Wegener's granulomatosis, Churg-Strauss syndrome, microscopic polyangiitis). 3. Therapeutic procedure].
Reinhold-Keller E; Tatsis E; Gross WL
Z Rheumatol; 1995; 54(5):303-9. PubMed ID: 8578886
[TBL] [Abstract][Full Text] [Related]
36. The lung in systemic vasculitis.
Leatherman JW
Semin Respir Infect; 1988 Sep; 3(3):274-88. PubMed ID: 2903521
[TBL] [Abstract][Full Text] [Related]
37. Relapses in patients with a systemic vasculitis.
Gordon M; Luqmani RA; Adu D; Greaves I; Richards N; Michael J; Emery P; Howie AJ; Bacon PA
Q J Med; 1993 Dec; 86(12):779-89. PubMed ID: 7906421
[TBL] [Abstract][Full Text] [Related]
38. Venous thromboembolism in ANCA-associated vasculitis--incidence and risk factors.
Stassen PM; Derks RP; Kallenberg CG; Stegeman CA
Rheumatology (Oxford); 2008 Apr; 47(4):530-4. PubMed ID: 18356178
[TBL] [Abstract][Full Text] [Related]
39. Treatment of polyarteritis nodosa and Churg-Strauss syndrome. A meta-analysis of 3 prospective controlled trials including 182 patients over 12 years.
Guillevin L; Lhote F; Jarrousse B; Fain O
Ann Med Interne (Paris); 1992; 143(6):405-16. PubMed ID: 1363508
[TBL] [Abstract][Full Text] [Related]
40. Renal transplant in Wegener's granulomatosis compared to microscopic polyangiitis.
Geetha D; Haas M; Kraus ES; Rabb H; Seo P
J Rheumatol; 2010 Aug; 37(8):1705-8. PubMed ID: 20516028
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
